Becton Dickinson falls after lowering profit forecast

Becton Dickinson and

10/02/2026 10:52

** Shares of medical device maker Becton Dickinson BDX.N fall 15.6% premarket

** Stock trading ~28% below its record high in 2023

** Co on Monday lowered its fiscal 2026 profit forecast below Wall Street estimates following the sale of its bioscience and diagnostics unit

** BDX now expects fiscal 2026 adjusted EPS of $12.35 to $12.65, down from its prior view of $14.75 to $15.05

** The lowered forecast overshadowed the co's better-than-expected Q1 results, where quarterly adj. profit of $2.91 per share beat estimates of $2.81 per share

** Co cites challenges around China's volume-based procurement program, tariffs and the weak performance of its Alaris infusion pump line

** Stock had climbed ~7% YTD before the drop, vs. a 2% rise in the S&P 500 .SPX

(Reporting by Medha Singh in Bengaluru)

((Medha.Singh@thomsonreuters.com; +91 80 6210 0592; X, formerly Twitter: @medhasinghs;))